Hyperelodiones A-C, Monoterpenoid Polyprenylated Acylphoroglucinols from Hypericum Elodeoides, Induce Cancer Cells Apoptosis by Targeting RXRα.

Daren Qiu,Mi Zhou,Junjie Chen,Guanghui Wang,Ting Lin,Yujie Huang,Furong Yu,Rong Ding,Cuiling Sun,Wenjing Tian,Haifeng Chen
DOI: https://doi.org/10.1016/j.phytochem.2019.112216
IF: 3.8
2020-01-01
Phytochemistry
Abstract:Hyperelodiones A-C, three undescribed monoterpenoid polyprenylated acylphloroglucinols possessing 6/6/6 fused tricyclic core, were isolated from Hypericum elodeoides Choisy. Their gross structures were elucidated by HRESIMS and NMR data. The absolute configurations of hyperelodiones A-C were assigned by their calculated and compared electronic circular dichroism (ECD) spectra combined with their common biosynthetic origin. A fluorescence quenching assay suggested that hyperelodiones A-C could bind to RXRα-LBD, whereas hyperelodione C showed the strongest interaction with a KD of 12.81 μΜ. In addition, hyperelodiones A-C dose-dependently inhibited RXRα transactivation and the growth of HeLa and MCF-7 cells. Among them, hyperelodione C showed the most potent inhibitory activities and dose-dependent PARP cleavage. Molecular docking results suggested that hyperelodione C showed a different interaction mode compared with hyperelodione A and hyperelodione B. Thus, hyperelodione C can be considered as a promising lead compound for cancer therapy, which can bind to RXRα-LBD and induce HeLa and MCF-7 cell apoptosis.
What problem does this paper attempt to address?